Memorial Sloan Kettering medical oncologist Gilles Salles

Areas of Expertise

Conditions I Treat

  • Hodgkin lymphoma (Hodgkin’s disease)
  • Non-Hodgkin lymphoma (NHL)
  • Follicular zone lymphoma

My Specialties

  • Immunotherapy
  • Cellular therapy
  • Targeted therapy
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a medical oncologist devoted to caring for people with hematologic cancers, including lymphoma and chronic lymphocytic leukemia. While I have broad experience in all subtypes of lymphoma, I have a particular expertise in treating diffuse large B-cell, follicular, and other B-cell lymphoma.

After 35 years of practice, I continue to be impressed by patients as they courageously fight these diseases. I value the exchanges I have with my patients and their families and take the time to answer their questions and explain the latest advances available to help manage their illness. These include immunotherapy, targeted therapy, chemotherapy and radiation therapy.

As a member of MSK’s Lymphoma Service Disease Management Team, I work closely with colleagues in other disciplines to formulate the best possible treatment plan that meets the specific needs of each patient.

I see patients in Manhattan at MSK Koch, which offers nearly every aspect of outpatient cancer care across many specialties, so most patients can get all their treatments in one place. The state-of-the-art facility was designed to help restore patients’ health and well-being.

My passion for hematology oncology emerged during my residency. I was drawn to the dual challenge of bringing faster scientific progress to people suffering from cancer and providing medical care for those patients over the entire course of their disease. As my career became deeply focused on lymphoma, I have been fortunate to see major improvements in diagnosis and treatment achieved over the last three decades.

It has been gratifying to be personally involved in some of these advances. For example, in recent years, I contributed to the development of immunotherapies (such as monoclonal antibodies and CAR T cell therapy) for people with B cell lymphoma.

I continue to be dedicated to various aspects of clinical research, including large studies that aim to establish the best standards of care and trials that are evaluating the safety and effectiveness of new treatments that may ultimately lead to new drug approvals. When our research staff determines that a patient is eligible to enroll in one of our clinical studies, we offer that individual the opportunity to participate as part of their care plan.

I moved to New York from Lyon, France with my wife in 2020 to join MSK as Chief of the Lymphoma Service. She and I enjoy listening to live music in our spare time and we are excited about getting into the jazz music scene in the city. It’s such a pleasure when we come across talented musicians during our walks through Central Park.

What I Do at MSK

I'm a lymphoma specialist, which is a doctor with special training in diagnosing and treating lymphoma (lim-FOH-muh). This cancer starts in the cells of the immune system.

A cellular therapy specialist is a doctor with special training in using cell therapies to treat health conditions such as cancer. Therapies can include chimeric antigen receptor (CAR) T cell therapy.

  • Chief, Lymphoma Service, Steven A. Greenberg Chair
Areas of Expertise

Conditions I Treat

  • Hodgkin lymphoma (Hodgkin’s disease)
  • Non-Hodgkin lymphoma (NHL)
  • Follicular zone lymphoma
  • B cell lymphoma
  • Diffuse large b-cell lymphoma (DLBCL)
  • Mucosa-associated lymphoid tissue lymphoma (MALT)
  • Marginal zone lymphomas
  • Lymphoma
  • Chronic lymphocytic leukemia (CLL)
  • Blood, bone marrow, and hematologic cancers and conditions

My Specialties

  • Immunotherapy
  • Cellular therapy
  • Targeted therapy
  • Chemotherapy
  • CAR T-cell therapy
  • Clinical trials
Education & Honors

Education

  • MD, University Claude Bernard, Lyon France
  • PhD, University Claude Bernard, Lyon France

Residencies

  • Internal Medicine, Lyon University Hospitals (1984-1989)

Fellowships

  • Hemato-Oncology, Lyon University Hospital - clinical
  • Harvard Medical School - research

Board Certifications

  • Internal Medicine, French Board of Physicians (1989)
  • Oncology, French Board of Physicians (1992)

Awards and Honors

  • Jose Carreras Award, European Hematology Association (2020)
  • Steven Greenberg Chair at Memorial Sloan Kettering Cancer Center (2021)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Cellular Therapy Service doctors

See all Lymphoma Service doctors

Clinical Trials

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Gilles Salles discloses the following relationships and financial interests:

  • AbbVie
    Professional Services and Activities
  • BeiGene USA, Inc.
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • Ellipses Pharma
    Professional Services and Activities
  • Foresight Diagnostics, Inc.
    Professional Services and Activities
  • Genentech
    Professional Services and Activities
  • GenMab
    Professional Services and Activities
  • Gilead Sciences, Inc.
    Professional Services and Activities
  • Ipsen Pharma
    Professional Services and Activities
  • Janssen Global Services, LLC
    Professional Services and Activities
  • Lilly USA, LLC
    Professional Services and Activities
  • Medscape
    Professional Services and Activities
  • ModeX Therapeutics Inc.
    Professional Services and Activities
  • Novartis
    Professional Services and Activities
  • Pfizer, Inc.
    Professional Services and Activities
  • Research to Practice
    Professional Services and Activities
  • Roche
    Professional Services and Activities
  • Scientific Education Support Ltd.
    Professional Services and Activities
  • SERB Pharmaceuticals
    Professional Services and Activities
  • Treeline Biosciences, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures